Cumulative insults to mitochondrial function may promote the emergence of 'syndrome X' and diabetes mellitus in HIV/HCV co-infected patients

Mitochondrion

Volumn 4, Issue 2-3, 2004, Pages 175-184

  Revuelta, Manuel P ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Antiretroviral; Hepatitis; HIV; Liver; Mitochondria; Tumor necrosis factor

Indexed keywords

ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR; RECOMBINANT ALPHA INTERFERON; RIBAVIRIN; RNA DIRECTED DNA POLYMERASE INHIBITOR;

CARDIOVASCULAR DISEASE; DIABETES MELLITUS; DISEASE PREDISPOSITION; HEPATITIS C; HIGH RISK PATIENT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLIC SYNDROME X; MITOCHONDRIAL TOXICITY; MITOCHONDRION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SUPERINFECTION; UNITED STATES;

HEPATITIS C VIRUS;

EID: 9244229073     PISSN: 15677249     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mito.2004.06.008     Document Type: Review

References (134)

1. A. Aceti C. Pasquazzi B. Zechini C. De Bac Hepatotoxicity development during antiretroviral therapy containing protease inhibitors in patients with HIV: The role of hepatitis B and C virus infection J. Acquir. Immune Defic. Syndr. 29 2002 41-48
2. L. Adinolfi M. Gambardella A. Andreana M. Tripodi R. Utili G. Ruggiero Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity Hepatology 33 2001 1358-1364
3. L. Adinolfi R. Utili A. Andreana M. Tripodi M. Marracino M. Gambardella M. Girodano G. Ruggiero Serum HCV RNA levels correlate with histological liver damage and concur with steatosis in progression of chronic hepatitis C Dig. Dis. Sci. 46 2001 1677-1683
4. P. Aukrust F. Muller E. Lien I. Nordoy N. Liabakk D. Kvale T. Espevik S. Froland Tumor necrosis factor (TNF) system levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy: Persistent TNF activation is associated with virologic and immunologic treatment failure J. Infect. Dis. 179 1999 74-82
5. G. Barbaro G. Di Lorenzo A. Asti M. Ribersani G. Belloni B. Grisorio G. Filice G. Barbarini Hepatocellular mitochondrial alterations in patients with chronic hepatitis C: Ultrastructural and biochemical findings Am. J. Gastroenterol. 94 1999 2198-2205
6. G. Barbaro G. Di Lorenzo G. Belloni A. Asti A. Pellicelli G. Barbarini Hepatic iron storage and megamitochondria formation in patients with chronic hepatitis C related to the hepatitis C virus genotype Dig. Liver Dis. 33 2001 81-83
7. C. Berdanier Mitochondrial gene expression in diabetes mellitus: Effect of nutrition Nutr. Rev. 59 2001 61-70
8. S. Bhayana R. Hegele The molecular basis of genetic lipodystrophies Clin. Biochem. 35 2002 171-177
9. I. Bica B. McGovern R. Dhar D. Stone K. McGowan R. Scheib D. Snydman Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection Clin. Infect. Dis. 32 2001 492-497
10. F. Bonnet M. Saves P. Morlat C. Droz E. Peuchant I. Pellegrin M. Bonarek N. Bernard D. Lacoste J. Beylot G. Chene Evolution of plasma levels of soluble interleukin-2 receptors (sIL2-R) and tumor necrosis factor type II (sTNFII-R) receptors is correlated with immunologic or virologic responses of patients treated by protease inhibitor-containing regimen Eighth Conference on Retroviruses and Opportunistic Infections, Chicago, Abstract 63 2000
11. K. Brinkman J. Smetnik J. Romijn P. Reiss Mitochondrial toxicity induced by nucleoside-analogue reverse transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy Lancet 354 1999 1112-1115
12. E. Bugianesi N. Leone E. Vanni G. Marchesini F. Brunello P. Carucci A. Musso P. De Paolis L. Capussotti M. Salizzoni M. Rizzetto Expanding the natural history of nonalcoholic steatohepatitis: From cryptogenic cirrhosis to hepatocellular carcinoma Gastroenterology 123 2002 134-140
13. S. Caldwell R. Swerdlow E. Khan J. Iezzoni E. Hespenheide J. Parks W. Parker Mitochondrial abnormalities in non-alcoholic steatohepatitis J. Hepatol. 31 1999 430-434
14. S. Caronia K. Taylor L. Pagliaro C. Carr U. Palazzo J. Petrik S. O'Rahilly S. Shore B. Tom G. Alexandar Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection Hepatology 30 1999 1059-1063
15. M.S. Cauble R. Gilroy M. Sorrell M. Mailliard D. Sudan J. Anderson J. Wisecarver S. Balakrishnan J. Larsen Lipoatrophic diabetes and end-stage liver disease secondary to nonalcoholic steatohepatitis with recurrence after liver transplantation Transplantation 71 2001 892-895
16. J. Cechetto R. Gupta Immunoelectron microscopy provides evidence that tumor necrosis factor receptor associated protein 1 (TRAP 1) is a mitochondrial protein which also localizes at extramitochondrial sites Exp. Cell Res. 260 2000 30-39
17. Centers for Disease Control and Prevention, January 18, 2000. US AIDS Incidience 1995-1998. Available at http://www.cdc.gov/hiv/graphicssurveill.htm
18. G. Chene E. Angelini L. Cotte J. Lang P. Morlat C. Rancinan T. May V. Journot F. Raffi B. Jarrousse M. Grappin G. Lepeu J. Molina Role of long-term nucleoside-analogue therapy in lipodystrophy and metabolic disorders in human immunodeficiency virus-infected patients Clin. Infect. Dis. 34 2002 649-657
19. S. Chitturi G. Farrell Etiopathogenesis of nonalcoholic steatohepatitis Semin. Liver Dis. 21 2001 27-41
20. A. Cossarizza L. Troiano C. Mussini Mitochondria and HIV infection J. Biol. Regul. Homeost. Agents 16 2002 18-24
21. J. Crespo A. Cayon P. Fernandez-Gil M. Hernandez-Guerra M. Mayorga A. Dominguez-Diez J. Fernandez-Escalante F. Pons-Romero Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients Hepatology 34 2001 1158-1163
22. B. Cribier C. Schmitt D. Rey G. Uhl J. Lang D. Vetter A. Kirn F. Stoll-Keller HIV increases hepatitis C viremia irrespective of the hepatitis C virus genotype Res. Virol. 148 1997 267-271
23. A. Czaja H. Carpenter P. Santrach S. Moore Host- and disease-specific factors affecting steatosis in chronic hepatitis C J. Hepatol. 29 1998 198-206
24. E. Daar H. Lynn S. Donfield E. Gomperts M. Hilgartner W. Hoots D. Chernoff S. Arkin W. Wong C. Winkler Relation between HIV-1 and hepatitis C viral load in patients with hemophilia J. Acquir. Immune Defic. Syndr. 26 2001 466-472
25. M. Dodig A. Tavill Hepatitis C and human immunodeficiency virus coinfections J. Clin. Gastroenterol. 33 2001 367-374
26. M. Duong J. Petit L. Piroth M. Grappin M. Buisson P. Chavanet P. Hillon H. Portier Association between insulin resistance and hepatitis C virus chronic infection in HIV-heaptitis C virus-coinfected patients undergoing antiretroviral therapy J. Acquir. Immune Defic. Syndr. 27 2001 245-250
27. C. Fabris G. Soardo E. Falleti P. Toniutto D. Vitulli E. Federico M. Del Forno M. Mattiuzzo F. Gonano M. Pirisi Relationship among hepatic inflammatory changes, circulating levels of cytokines, and response to IFN-alpha in chronic hepatitis C J. Interferon Cytokine Res. 18 1998 705-709
28. K. Ferri E. Jacotot J. Blanco J. Este G. Kroemer Mitochondrial control of cell death induced by HIV-1-encoded proteins Ann. NY Acad. Sci. 926 2000 149-164
29. E. Ford W. Giles W. Dietz Prevalence of the metabolic syndrome among US adults J. Am. Med. Assoc. 287 2002 356-359
30. N. Friis-Moller C.A. Sabin R. Weber A. d'Arminio Monforte W. El-Sadr P. Reiss R. Thiebaut L. Morfeldt S. De Wit C. Pradier G. Calvo M. Law O. Kirk A. Phillips J. Lundgren Combination antiretroviral therapy and the risk of myocardial infarction N. Engl. J. Med. 349 2003 1993-2003
31. N. Fukagawa M. Li P. Liang J. Russell B. Sobel P. Absher Aging and high concentrations of glucose potentiate injury to mitochondrial DNA Free Radic. Biol. Med. 27 1999 1437-1443
32. R. Fukuda N. Ishimura S. Ishihara A. Chowdhury N. Morlyama C. Nogami T. Miyake M. Niigaki A. Tokuda S. Satoh S. Sakai S. Akagi M. Watanabe S. Fukumoto Intrahepatic expression of pro-inflammatory cytokine mRNA's and interferon efficacy in chronic hepatitis C Liver 16 1996 390-399
33. J. Garcia-Samaniego M. Rodriguez J. Berenguer R. Rodriguez-Rosado J. Carbo V. Asensi V. Soriano Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C Am. J. Gastroenterol. 96 2001 179-183
34. C. Gazzaruso P. Sacchi A. Garzaniti P. Fratino R. Bruno G. Filice Prevalence of metabolic syndrome among HIV patients Diabetes Care 25 2002 1253-1254
35. K. Gerbitz J. van den Ouweland J. Maassen M. Jaksch Mitochondrial diabetes mellitus: A review Biochim. Biophys. Acta 1271 1995 253-260
36. A. Graber Syndrome of lipodystrophy, hyperlipidemia, insulin resistance, and diabetes in treated patients with human immunodeficiency virus infection Endocr. Pract. 7 2001 430-437
37. G. Greub B. Ledergerber M. Battegay P. Grob L. Perrin H. Furrer P. Burgisser P. Erb K. Boggian J.C. Piffaretti B. Hirschel P. Janin P. Francioli M. Flepp A. Telenti Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: The Swiss HIV Cohort Study Lancet 356 2000 1800-1805
38. S. Grimbert P. Valensi C. Levy-Marchal G. Perret J. Richardet C. Raffoux J. Trinchet M. Beaugrand High prevalence of diabetes mellitus in patients with chronic hepatitis C. A case-control study Gastroenterol. Clin. Biol. 20 1996 544-548
39. C. Grunfeld K. Feingold Metabolic disturbances and wasting in the acquired immune deficiency syndrome N. Engl. J. Med. 327 1992 329-337
40. R. Halse S. Pearson J. McCormack S. Yeaman R. Taylor Effects of tumor necrosis factor-alpha on insulin action in cultured human muscle cells Diabetes 50 2001 1102-1109
41. A. Hanley A. Karter A. Festa R. D'Agostino Jr L. Wagenknecht P. Savage R. Tracy M. Saad S. Haffner Factor analysis of metabolic syndrome using directly measured insulin sensitivity: The insulin resistance atherosclerosis study Diabetes 51 2002 2642-2647
42. H. Hardy L. Esch G. Morse Glucose disorders associated with HIV and its drug therapy Ann. Pharmacother. 35 2001 343-351
43. M. Higuchi B. Agarwal E. Yeh Activation of CPP32-like protease in tumor necrosis factor-induced apoptosis is dependent on mitochondrial function J. Clin. Invest. 99 1997 1751-1758
44. T. Hohler A. Kruger G. Gerken P. Schneider K. Meyer zum Buschenfelde C. Rittner Tumor necrosis factor alpha promoter polymorphism at position-238 is associated with chronic active hepatitis C infection J. Med. Virol. 54 1998 173-177
45. A. Howard R. Klein E. Schoenbaum Association of hepatitis C infection and antiretroviral use with diabetes mellitus in drug users Clin. Iinfect. Dis. 36 2003 1318-1323
46. D. Hui Effects of HIV protease inhibitor therapy on lipid metabolism Prog. Lipid Res. 42 2003 81-92
47. E. Imano T. Kanda Y. Ishigami M. Kubota M. Ikeda M. Matsuhisa R. Kawamori Y. Yamasaki Interferon induces insulin resistance in patients with chronic active hepatitis C J. Hepatol. 28 1998 189-193
48. Y. Ito T. Okanoue M. Ishimori A. Akai K. Miura K. Yasuda Effects of long-term interferon-alpha treatment on glucose tolerance in patients with chronic hepatitis C J. Hepatol. 31 1999 215-220
49. Y. Itoh T. Okanoue N. Ohnishi M. Sakamoto K. Nishioji Y. Nakagawa M. Minami Y. Murakami K. Kashima Serum levels of soluble tumor necrosis factor receptors and effects of interferon therapy in patients with chronic hepatitis C virus infection Am. J. Gastroenterol. 94 1999 1332-1340
50. R. Jain E. Furfine L. Pedneault A. White J. Lenhard Metabolic complications associated with antiretroviral therapy Antiviral Res. 51 2001 151-177
51. T. Kakuda Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity Clin. Ther. 22 2000 685-708
52. T. Kino M. Mirani C. Alesci G. Chrousos AIDS-related lipodystrophy/insulin resistance syndrome Horm. Metab. Res. 35 2003 129-136
53. H. Knobler T. Zhornicky A. Sandler N. Haran Y. Ashur A. Schattner Tumor necrosis factor-alpha-induced insulin resistance may mediate the hepatitis C virus-diabetes association Am. J. Gastroenterol. 98 2003 2751-2756
54. T. Konrad P. Vicini S. Zeuzem G. Toffolo D. Breim J. Lormann G. Herrmann D. Wittmann T. Lenz K. Kusterer G. Teuber C. Cobelli K. Usadel Interferon-alpha improves glucose tolerance in diabetic and non-diabetic patients with HCV-induced liver disease Exp. Clin. Endocrinol. Diabetes 107 1999 343-349
55. T. Konrad S. Zeuzem P. Vicini G. Toffolo D. Briem J. Lormann G. Herrmann A. Berger K. Kusterer G. Teuber C. Cobelli K. Usadel Severity of HCV-induced liver damage alters glucose homeostasis in noncirrhotic patients with chronic HCV infection Digestion 62 2000 52-59
56. A. Lafeuillade G. Hittinger S. Chadapaud Increased mitochondrial toxicity with ribavirin in HIV/HCV coinfection Lancet 357 2001 280-281
57. J. Lahdevirta C. Maury A. Teppo H. Repo Eleveated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome Am. J. Med. 85 1988 289-291
58. D. Langin Diabetes, insulin secretion, and the pancreatic beta-cell mitochondrion N. Engl. J. Med. 345 2001 1772-1774
59. G. Lauer B. Walker Hepatitis C virus infection N. Engl. J. Med. 345 2001 41-52
60. E. Ledgerwood J. Prins N. Bright D. Johnson K. Wolfreys J. Pober O'Rahilly J. Bradley Tumor necrosis factor is delivered to mitochondria where a tumor necrosis factor-binding protein is localized Lab. Invest. 78 1998 1583-1589
61. E. Ledgerwood J. Pober J. Bradley Recent advances in the molecular basis of TNF signal transduction Lab. Invest. 79 1999 1041-1050
62. E. Ledru N. Christeff O. Patey P. de Truchis J. Melchior M. Gougeon Alteration of tumor necrosis factor-α T-cell homeostasis following potent antiretroviral therapy: Contribution to the development of human immunodeficiency virus-associated lipodystrophy syndrome Blood 95 2000 3191-3198
63. P. Lofgren V. van Harmelen S. Reynisdottir E. Naslund M. Ryden S. Rossner P. Arner Secretion of tumor necrosis factor-alpha shows a strong relationship to insulin-stimulated glucose transport in human adipose tissue Diabetes 49 2000 688-692
64. P. Maechler C. Wollheim Mitochondrial signals in glucose-stimulated insulin secretion in the beta cell J. Physiol. 529 2000 49-56
65. P. Maechler C. Wollheim Mitochondrial function in normal and diabetic beta-cells Nature 414 2001 807-812
66. S.A. Mallal M. John C. Moore I. James E. McKinnon Protease inhibitors and nucleoside analogue reverse transcriptase inhibitors interact to cause subcutaneous fat wasting in patients with HIV infection Presented at the Seventh European Conference on Clinical Aspects and Treatment of HIV Infection, Lisbon, Portugal, Abstract 119 1999
67. L. Martin-Carbonero V. Soriano E. Valencia J. Garcia-Samaniego M. Lopez J. Gonzalez-Lahoz Increasing impact of chronic viral hepatitis on hospital admissions and mortality among HIV-infected patients AIDS Res. Hum. Retroviruses 17 2001 1467-1471
68. A. Mason J. Lau N. Hoang K. Qian G. Alexander L. Xu L. Guo S. Jacob F. Regenstein R. Zimmerman J. Everhart C. Wasserfall N. Maclaren R. Perrillo Association of diabetes mellitus and chronic hepatitis C virus infection Hepatology 29 1999 328-333
69. J. McHutchison T. Poynard R. Esteban-Mur G. Davis Z. Goodman J. Harvey M. Ling J. Garaud J. Albrecht K. Patel J. Dienstag T. Morgan Hepatic HCV RNA before and after treatment with interferon alone or combined with ribavirin Hepatology 35 2002 688-693
70. S. Mehta F. Brancati M. Sulkowski S. Strathdee M. Szklo D. Thomas Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States Ann. Intern. Med. 133 2000 592-599
71. S. Mehta R. Moore D. Thomas R. Chaisson M. Sulkowski The effect of HAART and HCV infection on the development of hyperglycemia among HIV-infected persons J. Acquir. Immune Defic. Syndr. 33 2003 577-584
72. N. Mikhail Insulin resistance in HIV-related lipodystrophy Curr. Hypertens. Rep. 5 2003 117-121
73. R. Molloy R. Komorowski R. Varma Recurrent nonalcoholic steatohepatitis and cirrhosis after liver transplantation Liver Transpl. Surg. 3 1997 177-178
74. H. Monga M. Rodriguez-Barradas K. Breaux K. Khattak C. Troisi M. Velez B. Yoffe Hepatitis C virus infection-related morbidity and mortality among patients with human immunodeficiency virus infection Clin. Infect. Dis. 33 2001 240-247
75. R. Moore J. Keruly G. Lucas Increasing incidence of cardiovascular disease in HIV-infected persons in care Presented at the 10th Conference on Retroviruses and Opportunistic Infections, Boston, USA, Abstract 132 2003
76. S. Moretti S. Marcellini A. Boschini G. Famularo G. Santini E. Alesse S. Steinberg M. Cifone G. Kroemer C. De Simone Apoptosis and apoptosis-associated perturbations of peripheral blood lymphocytes during HIV infection: Comparison between AIDS patients and long-term non-progressors Clin. Exp. Immunol. 122 2000 364-373
77. G. Mottola G. Cardinali A. Ceccacci C. Trozzi L. Bartholomew M. Torrisi E. Pedrazzini S. Bonatti G. Migliaccio Hepatitis C virus nonstructural proteins are localized in a modified endoplasmic reticulum of cells expressing viral subgenomic replicons Virology 293 2002 31-43
78. K. Mulligan V. Tai H. Algren D. Abrams R. Leiser J. Lo M. Schambelan Altered fat distribution in HIV-positive men on nucleoside analog reverse transcriptase inhibitor therapy J. Acquir. Immune Defic. Syndr. 26 2001 443-448
79. D. Mynarcik M. McNurlan R. Steigbigel J. Fuhrer M. Gelato Association of severe insulin resistance with both loss of limb fat and elevated serum tumor necrosis factor receptor lievels in HIV lipodystrophy J. Acquir. Immune Defic. Syndr. 25 2000 312-321
80. D. Nelson H. Lim C. Marousis J. Fang G. Davis L. Shen M. Urdea J. Kolberg J. Lau Activation of tumor necrosis factor-alpha system in chronic hepatitis C virus infection Dig. Dis. Sci. 42 1997 2487-2494
81. E. Nemesanszky M. Pusztay A. Csepregi Effects of interferon treatment on the glucose metabolism of patients with chronic hepatitis C Eur. J. Intern. Med. 11 3 2000 151-155
82. M. Neuman J. Benhamou M. Martinot N. Boyer N. Shear I. Malkiewicz G. Katz A. Suneja S. Singh P. Marcellin Predictors of sustained response to alpha interferon therapy in chronic hepatitis C Clin. Biochem. 32 7 1999 537-545
83. B. Neuschwander-Tetri Evolving pathophysiologic concepts in nonalcoholic steatohepatitis Curr. Gastroenterol. Rep. 4 2002 31-36
84. D. Nolan E. Hammond A. Martin L. Taylor S. Herrmann E. Mckinnon C. Metcalf B. Latham S. Mallal Mitochondrial DNA depletion and morphologic changes in adipocytes associated with nucleoside reverse transcriptase inhibitor therapy Acquir. Immune Defic. Syndr. 17 2003 1329-1338
85. M. Nunez R. Lana J. Mendoza L. Martin-Carbonero V. Soriano Risk factors for severe hepatic injury after introduction of highly active antiretroviral therapy J. Acquir. Immune Defic. Syndr. 27 2001 426-431
86. J. Ockenga H. Tillmann C. Trautwein M. Stoll M. Manns R. Schmidt Hepatitis B and C in HIV-infected patients. Prevalence and prognostic value J. Hepatol. 27 1997 18-24
87. M. Okuda K. Li M. Beard L. Showalter F. Scholle S. Lemon S. Weinman Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein Gastroenterology 122 2002 366-375
88. A. Onat K. Ceyhan O. Basar B. Erer S. Toprak V. Sansoy Metabolic syndrome: Major impact on coronary risk in a population with low cholesterol levels-a prospective and cross-sectional evaluation Atherosclerosis 165 2002 285-292
89. J. Ong Z. Younossi C. Speer A. Olano T. Gramlich N. Boparai Chronic hepatitis C and superimposed nonalcoholic fatty liver disease Liver 21 2001 266-271
90. V. Ortiz M. Berenguer J. Rayon D. Carrasco J. Berenguer Contribution of obesity to hepatitis C-related fibrosis progression Am. J. Gastroenterol. 97 2002 2408-2414
91. O. Ozes H. Akca L. Mayo J. Gustin T. Maehama J. Dixon D. Donner A phosphatidylinositol 3-kinase/Akt/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1 Proc. Natl Acad. Sci. USA 98 2001 4640-4645
92. V. Paradis G. Perlemuter F. Bonvoust D. Dargere B. Parfait M. Vidaud M. Conti S. Huet N. Ba C. Buffet P. Bedossa High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: A potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis Hepatology 34 2001 738-744
93. K. Park K. Lee J. Song C. Choi C. Shin D. Park S. Kim J. Koh H. Lee Peripheral blood mitochondrial DNA content is inversely correlated with insulin secretion during hyperglycemic clamp studies in healthy young men Diabetes Res. Clin. Pract. 52 2001 97-102
94. J. Pastorino G. Simbula K. Yamamoto P. Glascott Jr R. Rothman J. Farber The cytotoxicity of tumor necrosis factor depends on induction of the mitochondrial permeability transition pore J. Biol. Chem. 271 1996 29792-29799
95. Z. Pausova B. Deslauriers D. Gaudet J. Tremblay T. Kotchen P. Larochelle A. Cowley P. Hamet Role of tumor necrosis factor-alpha gene locus in obesity and obesity-associated hypertension in French Canadiens Hypertension 36 2000 14-19
96. D. Pessayre A. Mansouri D. Haouzi B. Fromenty Hepatotoxicity due to mitochondrial dysfunction Cell Biol. Toxicol. 15 1999 367-373
97. D. Pessayre A. Berson B. Fromenty A. Mansouri Mitochondria in steatohepatitis Semin. Liver Dis. 21 2001 57-69
98. D. Pessayre A. Mansouri B. Fromenty Nonalcoholic steatosis and steatohepatitis. V. Mitochondrial dysfunction in steatohepatitis Am. J. Physiol. Gastrointest. Liver Physiol. 282 2002 G193-G199
99. K. Petersen S. Dufour D. Befroy R. Garcia G. Shulman Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes N. Engl. J. Med. 350 2004 664-671
100. J. Petit J. Bour C. Galland-Jos A. Minello B. Verges M. Guiguet J. Brun P. Hillon Risk factors for diabetes melitus and early insulin resistance in chronic hepatitis C J. Hepatol. 35 2001 279-283
101. W. Powderly Long-term exposure to lifelong therapies J. Acquir. Immune Defic. Syndr. 29 2002 S28-S40
102. M. Puoti M. Bonacini A. Spinetti V. Putzolu S. Govindarajan S. Zaltron M. Favret F. Callea F. Gargiulo F. Donato G. Carosi Liver fibrosis is related to CD4 depletion in patients coinfected with hepatitis C virus and human immunodeficiency virus J. Infect. Dis. 183 2001 134-137
103. V. Ratziu L. Bonyhay V. Di Martino F. Charlotte L. Cavallaro M. Sayegh-Tainturier P. Giral A. Grimaldi P. Opolon T. Poynard Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis Hepatalogy 35 2002 1485-1493
104. R. Roggero V. Robert-Hebmann S. Harrington J. Roland L. Vergne S. Jaleco C. Devaux M. Biard-Piechaczyk Binding of human immunodeficiency virus type 1 gp120 to CXCR4 induces mitochondrial transmembrane depolarization and cytochrome c-mediated apoptosis independently of Fas signaling J. Virol. 75 2001 7637-7650
105. H. Rosen J. Lentz S. Rose J. Rabkin C. Corless K. Taylor S. Chou Donor polymorphism of tumor necrosis factor gene: Relationship with variable severity of hepatitis C recurrence after liver transplantation Transplantation 68 1999 1898-1902
106. L. Rubbia-Brandt G. Leandro L. Spahr E. Giostra R. Quadri P. Male F. Negro Liver steatosis in chronic hepatitis C: A morphologic sign suggesting infection with HCV genotype 3 Histopathology 39 2001 119-124
107. C. Sabin P. Telfer A. Phillips S. Bhagani C. Lee The association between hepatitis C genotype and human immunodeficiency virus disease progression in a cohort of hemophiliac men J. Infect. Dis. 175 1997 164-168
108. E. Santagostino M. Rumi M. Rivi M. Colombo P. Mannucci Sustained suppression of hepatitis C virus by interferon and ribavirin in hemophiliac patients not responding to interferon monotherapy Blood 99 2002 1089-1091
109. A. Sanyal C. Campbell-Sargent F. Mirshahi W. Rizzo M. Contos R. Sterling V. Luketic M. Shiffman J. Clore Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities Gastroenterolgy 120 2001 1281-1285
110. A. Sanyal M. Contos R. Sterling V. Luketic M. Shiffman R. Stravitz A. Mills Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome Am. J. Gastroenterol. 98 2003 2064-2071
111. M. Saves F. Raffi J. Capeau W. Rozenbaum J. Ragnaud C. Perronne A. Basdevant C. Leport G. Chene Factors related to lipodystrophy and metabolic alterations in patients with human immunodeficiency virus infection receiving highly active antiretroviral therapy Clin. Infect. Dis. 34 2002 1396-1405
112. K. Schulze-Osthoff A. Bakker B. Vanhaesebroeck R. Beyaert W. Jacob W. Fiers Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions: Evidence for the involvement of mitochondrial radical generation J. Biol. Chem. 267 1992 5317-5323
113. L. Serfaty T. Andreani P. Giral N. Carbonell O. Chazouilleres R. Poupon Hepatitis C virus induced hypobetalipoproteinemia: A possible mechanism for steatosis in chronic hepatitis C J. Hepatol. 34 2001 428-434
114. K. Sherman C. Andreatta J. O'Brien A. Gutierrez R. Harris Hepatitis C in human immunodeficiency virus-coinfected patients: Increased variability in the hypervariable envelope coding domain Hepatology 23 1996 688-694
115. K.E. Sherman S.D. Rouster R.T. Chung N. Rajicic Hepatitis C virus prevalence among patients infected with human immunodeficiency virus: A cross-sectional analysis of the US Adult AIDS Clinical Trials Group Clin. Infect. Dis. 34 2002 831-837
116. S. Shi S. Polyak H. Tu D. Taylor D. Gretch M. Lai Hepatitis C virus NS5A colocalizes with the core protein on lipid droplets and interacts with apolipoproteins Virology 292 2002 198-210
117. C. Shikuma N. Hu C. Milne F. Yost C. Waslien S. Shimizu B. Shiramizu Mitochondrial DNA decrease in subcutaneous adipose tissue of HIV-infected individuals with peripheral lipoatrophy Acquir. Immune Defic. Syndr. 15 2001 1801-1809
118. J. Song J. Oh Y. Sung Y. Pak K. Park K. Lee Peripheral blood mitochondrial DNA content is related to insulin sensitivity in offspring of type 2 diabetic patients Diabetes Care 24 2001 865-869
119. M. Sulkowski D. Thomas Hepatitis C in the HIV-infected patient Ann. Intern. Med. 138 2003 197-207
120. M. Tawata J. Hayashi K. Isobe E. Ohkubo M. Ohtaka J. Chen K. Aida T. Onaya A new mitochondrial DNA mutation at 14577 T/C is probably a major pathogenic mutation for maternally inherited type 2 diabetes Diabetes 49 2000 1269-1272
121. H. Tilg A. Diehl Cytokines in alcoholic and nonalcoholic steatohepatitis N. Engl. J. Med. 343 2001 1467-1476
122. C. Tsigos I. Kyrou E. Chala P. Tsapogas J. Stavridis S. Raptis N. Katsilambros Circulating tumor necrosis factor alpha concentrations are higher in abdominal versus peripheral obesity Metabolism 48 1999 1132-1135
123. S. Tsiodras C. Mantzoros S. Hammer M. Samore Effects of protease inhibitors on hyperglycemia, hyperlipidemia, and lipodystropy: A 5-year cohort study Arch. Intern. Med. 160 2000 2050-2056
124. L. Valenti A.L. Francazani P. Dongiovanni G. Santorelli A. Branchi E. Taioli G. Fiorelli S. Fargion Tumor necrosis factor alpha promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease Gastroenterology 122 2002 274-280
125. M. van der Valk P. Bisschop J. Romijn M. Ackermans J. Lange E. Endert P. Reiss H. Sauerwein Lipodystrophy in HIV-1-positive patients is associated with insulin resistance in multiple metabolic pathways Acquir. Immune Defic. Syndr. 15 2001 2093-2100
126. C. Vigouroux S. Gharakhanian Y. Salhi T. Nguyen D. Chevenne J. Capeau W. Rozenbaum Diabetes, insulin resistance and dyslipidemia in lipodystrophic HIV-infected patients on highly active antiretroviral therapy (HAART) Diabetes Metab. 25 1999 225-232
127. C. Vigouroux J. Magre C. Desbois-Mouthon O. Lascols G. Cherqui M. Caron J. Capeau Major insulin resistance syndromes: Clinical and physiopathological aspects J. Soc. Biol. 195 2001 249-257
128. U. Walker M. Bickel S. Lutke-Volksbeck U. Ketelsen H. Schofer B. Setzer N. Venhoff V. Rickerts S. Staszewski Evidence of nucleoside analogue reverse transcriptase inhibitor-associated genetic and structural defects of mitochondria in adipose tissue of HIV-infected patients J. Acquir. Immune Defic. Syndr. 29 2002 117-121
129. C. Wanke J. Falutz A. Shevitz J. Phair D. Kotler Clinical evaluation and management of metabolic and morphologic abnormalities associated with human immunodeficiency virus Clin. Infect. Dis. 34 2002 248-259
130. I. Willner B. Waters S. Patil A. Reuben J. Morelli C. Riely Ninety patients with nonalcoholic steatohepatitis: Insulin resistance, familial tendency, and severity of disease Am. J. Gastroenterol. 96 2001 2957-2961
131. R. Woitas J. Rockstroh I. Beier G. Jung B. Kochan B. Matz H. Brackmann T. Sauerbruch U. Spengler Antigen-specific cytokine response to hepatitis C virus core epitopes in HIV/hepatitis C virus-coinfected patients Acquir. Immune Defic. Syndr. 13 1999 1313-1322
132. C. Wollheim Beta-cell mitochondria in the regulation of insulin secretion: A new culprit in type II diabetes Diabetologia 43 2000 265-277
133. L. Yee J. Tang J. Herrera R. Kaslow D. van Leeuwen Tumor necrosis factor gene polymorphisms in patients with cirrhosis from chronic hepatitis C virus infection Genes Immun. 1 2000 386-390
134. Zylberberg H. Rimaniol A. Pol S. Masson A. De Groote D. Berthelot P. Bach J. Brechot C. Zavala F. 1999 Soluble tumor necrosis factor receptors in chronic hepatitis C: A correlation with histological fibrosis and activity. J. Hepatol. 30, 185-191